|
Cohance Lifesciences Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
20497.95 Cr.
|
P/BV
|
11.99
|
Book Value (Rs.)
|
44.68
|
|
52 Week High/Low (Rs.)
|
1328/521
|
FV/ML
|
1/1
|
P/E(X)
|
76.52
|
|
Bookclosure
|
09/08/2024
|
EPS (Rs.)
|
7.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 1172.28 | 1035.85 | 1331.11 | 1307.01 | 995.46 |
| Other Operating Revenues | 25.30 | 15.51 | 9.22 | 13.21 | 14.25 |
| Total Operating Revenues | 1197.58 | 1051.35 | 1340.33 | 1320.22 | 1009.72 |
| | | | | | |
| Other Income | 58.56 | 61.91 | 46.36 | 92.38 | 14.24 |
| Total Revenue | 1256.14 | 1113.26 | 1386.69 | 1412.60 | 1023.96 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 222.66 | 265.88 | 430.08 | 459.46 | 310.32 |
| Operating And Direct Expenses | 0.00 | 133.48 | 176.29 | 173.19 | 122.73 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 82.63 | 49.16 | -20.94 | -60.35 | -8.37 |
| Employee Benefit Expenses | 249.56 | 135.92 | 110.51 | 100.48 | 87.29 |
| Finance Costs | 12.35 | 7.45 | 5.44 | 6.23 | 9.14 |
| Depreciation And Amortisation Expenses | 77.49 | 54.60 | 47.73 | 39.10 | 31.64 |
| Other Expenses | 267.53 | 61.11 | 77.86 | 68.02 | 57.27 |
| Total Expenses | 912.22 | 707.59 | 826.96 | 786.12 | 610.02 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 343.92 | 405.67 | 559.73 | 626.48 | 413.94 |
| | | | | | |
| Profit/Loss Before Tax | 343.92 | 405.67 | 559.73 | 626.48 | 413.94 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 86.77 | 99.58 | 146.27 | 190.40 | 101.54 |
| Deferred Tax | -14.19 | 6.59 | 4.34 | 23.38 | 3.62 |
| Tax For Earlier Years | 6.57 | -0.78 | -2.17 | 0.00 | 0.18 |
| Total Tax Expenses | 79.15 | 105.39 | 148.44 | 213.79 | 105.33 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 264.77 | 300.28 | 411.29 | 412.69 | 308.61 |
| | | | | | |
| Profit/Loss From Continuing Operations | 264.77 | 300.28 | 411.29 | 412.69 | 308.61 |
| | | | | | |
| Profit/Loss For The Period | 264.77 | 300.28 | 411.29 | 412.69 | 308.61 |
| | | | | | |
| Minority Interest | 3.10 | 0.00 | 0.00 | 0.00 | 0.00 |
| Share Of Profit/Loss Of Associates | 0.00 | 0.00 | 0.00 | 41.11 | 53.74 |
| Consolidated Profit/Loss After MI And Associates | 267.87 | 300.28 | 411.29 | 453.80 | 362.34 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 10.52 | 11.80 | 16.16 | 17.83 | 14.23 |
| Diluted EPS (Rs.) | 10.45 | 11.80 | 16.16 | 17.83 | 14.23 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 0.00 | 0.00 | 203.65 | 101.83 | 25.46 |
